Provided by Tiger Fintech (Singapore) Pte. Ltd.

Praxis Precision Medicines, Inc.

35.98
+0.64001.81%
Post-market: 35.980.00000.00%16:30 EDT
Volume:501.93K
Turnover:18.18M
Market Cap:725.47M
PE:-3.52
High:37.09
Open:35.79
Low:35.53
Close:35.34
Loading ...

Stock Track | Praxis Precision Medicines Soars on Promising Clinical Updates and Strong Financials

Stock Track
·
08 Nov 2024

Praxis Precision Med Price Target Maintained With a $151.00/Share by Needham

Dow Jones
·
07 Nov 2024

Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ...

GuruFocus.com
·
07 Nov 2024

Promising Prospects and Financial Stability: Ritu Baral’s Buy Recommendation for Praxis Precision Medicines

TIPRANKS
·
07 Nov 2024

Wedbush Raises Praxis Precision Medicines Price Target to $57 From $51, Maintains Neutral Rating

MT Newswires Live
·
07 Nov 2024

Stock Track | Praxis Precision Medicines Plunges on Wider-Than-Expected Q3 Loss

Stock Track
·
06 Nov 2024

Praxis Precision Medicines Q3 Net Loss Widens, Collaboration Revenue Falls; Shares Drop Pre-Bell

MT Newswires Live
·
06 Nov 2024

Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates

Zacks
·
06 Nov 2024

Praxis Precision Medicine Q3 2024 GAAP EPS $(2.75) Misses $(1.99) Estimate, Sales $302.000K Beat $296.000K Estimate

Benzinga
·
06 Nov 2024

Praxis Precision Medicines: Maintains Runway Into 2027

THOMSON REUTERS
·
06 Nov 2024

Praxis Precision Q3 Collaboration Revenue USD 302 Thousand

THOMSON REUTERS
·
06 Nov 2024

Press Release: Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Dow Jones
·
06 Nov 2024

Praxis Precision Medicines Inc expected to post a loss of $1.99 a share - Earnings Preview

Reuters
·
04 Nov 2024

Praxis Precision Med Is Maintained at Outperform by Oppenheimer

Dow Jones
·
01 Nov 2024

Praxis Precision Medicines (PRAX) Receives a Buy from Oppenheimer

TIPRANKS
·
31 Oct 2024